These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 30652006)

  • 1. Genetics of narcolepsy.
    Miyagawa T; Tokunaga K
    Hum Genome Var; 2019; 6():4. PubMed ID: 30652006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution HLA sequencing and hypocretin receptor 2 autoantibodies in narcolepsy type 1 and type 2.
    Hamdan S; Wasling P; Lind A
    Int J Immunogenet; 2024 Oct; 51(5):310-318. PubMed ID: 38898624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-genome analysis of monozygotic Brazilian twins discordant for type 1 narcolepsy: a case report.
    Campos JHC; Aguilar ACR; Antoneli F; Truzzi G; Briones MRS; Ferreira RC; Coelho FMS
    BMC Neurol; 2022 Nov; 22(1):439. PubMed ID: 36401198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Narcolepsies, update in 2023.
    Barateau L; Pizza F; Chenini S; Peter-Derex L; Dauvilliers Y
    Rev Neurol (Paris); 2023 Oct; 179(7):727-740. PubMed ID: 37634997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of glymphatic function in narcolepsy using DTI-ALPS index.
    Gumeler E; Aygun E; Tezer FI; Saritas EU; Oguz KK
    Sleep Med; 2023 Jan; 101():522-527. PubMed ID: 36535226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Narcolepsy.
    Barateau L; Lopez R; Dauvilliers Y
    Curr Treat Options Neurol; 2016 Oct; 18(10):43. PubMed ID: 27549768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between human leukocyte antigen class II-DR-DQ and narcolepsy: a case control study.
    Bacelar A; Fernandez O; Paradella E; Rodrigues RN; de Castro Moreno CR; Alvarenga R
    J Clin Sleep Med; 2024 Dec; 20(12):1945-1953. PubMed ID: 39150697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between HLA-DQB1*06:02 and narcolepsy with and without cataplexy: approving a safe and sensitive genetic test in four major ethnic groups. A systematic meta-analysis.
    Capittini C; De Silvestri A; Terzaghi M; Scotti V; Rebuffi C; Pasi A; Manni R; Martinetti M; Tinelli C
    Sleep Med; 2018 Dec; 52():150-157. PubMed ID: 30321823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narcolepsy - clinical spectrum, aetiopathophysiology, diagnosis and treatment.
    Bassetti CLA; Adamantidis A; Burdakov D; Han F; Gay S; Kallweit U; Khatami R; Koning F; Kornum BR; Lammers GJ; Liblau RS; Luppi PH; Mayer G; Pollmächer T; Sakurai T; Sallusto F; Scammell TE; Tafti M; Dauvilliers Y
    Nat Rev Neurol; 2019 Sep; 15(9):519-539. PubMed ID: 31324898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Not Available].
    Monaca C; Franco P; Philip P; Dauvilliers Y
    Rev Neurol (Paris); 2017; 173(1-2):25-31. PubMed ID: 27838095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study.
    Ruoff C; Pizza F; Trotti LM; Sonka K; Vandi S; Cheung J; Pinto S; Einen M; Simakajornboon N; Han F; Peppard P; Nevsimalova S; Plazzi G; Rye D; Mignot E
    J Clin Sleep Med; 2018 Jan; 14(1):65-74. PubMed ID: 29198301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients.
    Evans R; Kimura H; Alexander R; Davies CH; Faessel H; Hartman DS; Ishikawa T; Ratti E; Shimizu K; Suzuki M; Tanaka S; Yukitake H; Dauvilliers Y; Mignot E
    Proc Natl Acad Sci U S A; 2022 Aug; 119(35):e2207531119. PubMed ID: 35994639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TAK-994, a Novel Orally Available Brain-Penetrant Orexin 2 Receptor-Selective Agonist, Suppresses Fragmentation of Wakefulness and Cataplexy-Like Episodes in Mouse Models of Narcolepsy.
    Ishikawa T; Hara H; Kawano A; Tohyama K; Kajita Y; Miyanohana Y; Koike T; Kimura H
    J Pharmacol Exp Ther; 2023 Jun; 385(3):193-204. PubMed ID: 37001988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic Archaerhodopsin-3 Expression in Hypocretin/Orexin Neurons Engenders Cellular Dysfunction and Features of Type 2 Narcolepsy.
    Williams RH; Tsunematsu T; Thomas AM; Bogyo K; Yamanaka A; Kilduff TS
    J Neurosci; 2019 Nov; 39(47):9435-9452. PubMed ID: 31628177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Narcolepsy during Childhood: An Update.
    Rocca FL; Pizza F; Ricci E; Plazzi G
    Neuropediatrics; 2015 Jun; 46(3):181-98. PubMed ID: 25961600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alexithymia, impulsiveness, emotion, and eating dyscontrol: similarities and differences between narcolepsy type 1 and type 2.
    Del Bianco C; Ulivi M; Liguori C; Pisani A; Mercuri NB; Placidi F; Izzi F
    Sleep Biol Rhythms; 2023 Jan; 21(1):39-50. PubMed ID: 38468909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium Oxybate Treatment in Pediatric Type 1 Narcolepsy.
    Moresco M; Pizza F; Antelmi E; Plazzi G
    Curr Drug Metab; 2018; 19(13):1073-1079. PubMed ID: 29512449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudotumor cerebri syndrome in a patient with narcolepsy type 1.
    Rossor T; Lim M; VanDenEshof K; Gringras P
    Eur J Paediatr Neurol; 2018 Jan; 22(1):194-198. PubMed ID: 29195824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in treatment for narcolepsy.
    Barateau L; Dauvilliers Y
    Ther Adv Neurol Disord; 2019; 12():1756286419875622. PubMed ID: 31632459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.